U.S. Professional Services Stock News

Oruka Therapeutics (ORKA) stock has drawn attention after a strong run over the past year, with the share price last closing at $69.89 and market value around $4.2b. See our latest analysis for Oruka Therapeutics. The recent move to $69.89 caps a strong run, with the share price return of 147.22% year to date and a 1 year total shareholder return of about 4.6x pointing to strong momentum rather than a short term spike. If you are looking beyond Oruka Therapeutics, this could be a good moment...

Recent performance snapshot MaxLinear (MXL) has seen mixed share price moves, with a gain of about 4.2% over the past week and a decline of roughly 8.5% over the past month, leaving the stock near US$84.46. See our latest analysis for MaxLinear. That recent 4.2% one-day share price move comes after a choppy month, with the share price down about 8.5% over 30 days but supported by very strong 90-day and 1-year total shareholder returns. This suggests momentum has been building over a longer...

BKV (BKV) is on investors’ radar after an eventful stretch that combined annual meeting decisions, a revised lending agreement that affects financial flexibility, and a reaffirmed bullish analyst stance paired with a more cautious short term view. See our latest analysis for BKV. BKV’s share price has softened recently, with a 30 day share price return down 12.1% and a year to date share price return down 8.7%. However, the 1 year total shareholder return is 7.5%. This suggests momentum has...

Earlier this month, HP Inc. unveiled the HP Limited Edition Scuderia Ferrari AI PC, a serialized US$5,599 collector device limited to 4,999 units, alongside a broader lineup of new AI-focused notebooks, desktops, and developer systems. The Ferrari collaboration and RTX Spark-powered developer PCs underscore HP’s push into premium and AI-centric computing, aiming to appeal to enthusiasts, creators, and enterprise AI developers alike. We’ll now examine how HP’s Ferrari-branded AI PC and...

Recently, Fabrinet highlighted how it is benefiting from rising automation and AI demand as a manufacturing partner for advanced optical transceivers, high-performance computing clusters, and industrial lasers, underpinned by a debt-free balance sheet. An interesting aspect is Fabrinet’s positioning as a preferred contract manufacturer for leading hyperscalers and networking companies, which could enhance its role across both optical and non-optical communications markets. Next, we’ll...

Event puts Pitolisant program and stock in the spotlight Harmony Biosciences Holdings (HRMY) is drawing fresh attention after six Pitolisant related abstracts were accepted for SLEEP 2026, along with reaffirmed revenue guidance and updated timelines for key regulatory and clinical milestones. See our latest analysis for Harmony Biosciences Holdings. The recent Pitolisant updates and reaffirmed outlook come as the stock trades at US$34.46, with a 30 day share price return of 14.52% and a 1...

Recent performance snapshot Ellington Financial (EFC) has drawn fresh attention after a recent move in its stock price, trading around $13.68 with a market value near $1.74b and total return figures provided across multiple periods. See our latest analysis for Ellington Financial. Recent trading has been relatively firm, with Ellington Financial’s 90 day share price return of 14.57% and 1 year total shareholder return of 19.73%. Investors may weigh this performance against income prospects...

Stevanato Group stock reaction and recent context Stevanato Group (STVN) shares recently closed at US$17.08, with the stock down about 5% over the past month but up roughly 11% over the past 3 months. See our latest analysis for Stevanato Group. Zooming out, the stock’s 11.27% 90 day share price return contrasts with a year to date share price decline of 17.01%, and a 1 year total shareholder return decline of 26.99%. This suggests that recent momentum is improving after a weaker longer term...

Curbline Properties Corp. recently raised fresh capital by filing an at-the-market follow-on equity program of up to US$400 million and completing US$120.27 million in common stock issuances at modest discounts to market. This move, combined with an analyst upgrade reflecting improved earnings expectations, highlights how Curbline is using equity markets to support its growth plans while sentiment around its business strengthens. Next, we’ll examine how Curbline’s at-the-market equity...

In early June 2026, SciTec Inc. announced it was selected by the U.S. Department of the Air Force PAE C3BM office to deliver a US$5.5 million operational data fusion system option under the Cloud-Based Command and Control program, building on an initial US$24.0 million award from 2024. This win highlights how SciTec’s cloud-based fusion software, now part of Firefly Aerospace, is being embedded in critical U.S. defense command-and-control infrastructure, reinforcing Firefly’s exposure to...

Atmus Filtration Technologies (ATMU) is back in focus after its late 2025 purchase of Koch Filter Corp, a move that is expected to lift EBITDA margins and EPS as the industrial filtration push takes shape. See our latest analysis for Atmus Filtration Technologies. The stock has recently moved out of a softer patch, with the 90-day share price return down 13.03% and the 30-day share price return down 3.56%. More recently, it has shown a stronger near-term tone, reflected in a 7-day share price...

NCR Voyix stock reacts to ESOP shelf registration and upcoming conference appearance NCR Voyix (VYX) has filed a roughly $77.3 million shelf registration tied to an ESOP related common stock offering, while investors also watch for commentary from its CFO at the RBC Capital Markets Global Financial Technology Conference. See our latest analysis for NCR Voyix. The stock’s recent 1 day share price return of 10.25% and 30 day share price return of 17.87% suggest short term momentum. However, the...

Axos Financial (AX) is back in focus after its latest earnings report, which combined strong year-over-year revenue and earnings growth with misses on net interest income and EPS estimates, a mix that weighed on investor sentiment. See our latest analysis for Axos Financial. Axos Financial’s share price has gained 8.5% over the past month and 6.9% over the past quarter to US$90.28. Its 1 year total shareholder return of 28.9% and 3 year total shareholder return of about 2.3x highlight...

Recent commentary on Enerpac Tool Group (EPAC) focuses on solid momentum in its Industrial Tools & Services segment and the acquisition of DTA, which together shape how investors may assess the stock today. See our latest analysis for Enerpac Tool Group. At a share price of $35.05, Enerpac Tool Group has rebounded in the short term, with a 7 day share price return of 4.78%. However, its year to date share price return is down 11.40% and the 1 year total shareholder return is down 16.80%, so...

Forestar Group (NYSE:FOR) is under pressure as persistently weak sales trends, negative free cash flow, and falling returns on capital raise concerns about recent investment decisions. These financial and operational strains point to possible value destruction from new projects and capital deployment. The situation is drawing fresh attention because it has not been widely discussed, despite potential implications for investor confidence and management credibility. For a company with a...

SEALSQ stock overview after recent trading performance SEALSQ (LAES) has drawn attention after recent trading left the stock down about 27% year to date, despite a market cap of roughly US$617m and reported revenue of US$18.252m from its semiconductor focused business. See our latest analysis for SEALSQ. At a share price of US$3.10, SEALSQ has seen its short term momentum cool, with the 1 day and 7 day share price returns both down about 3%. A 30 day share price return of roughly 8% contrasts...

First Ottawa Bancshares (FOTB) opened 2026 with Q1 revenue of US$19.4 million and basic EPS of US$24.46, alongside trailing 12 month revenue of US$75.6 million and EPS of US$27.05 that frame the latest quarter in a wider earnings run. Over recent periods, the company has seen revenue move from US$16.3 million in Q1 2025 to US$19.4 million in Q1 2026, while trailing 12 month EPS has shifted from US$20.79 at Q4 2024 to US$27.05 at Q1 2026. This sets the stage for investors to focus on how...

If you are wondering whether Clorox stock is starting to offer value again, the recent share price and valuation signals are giving you a fresh set of data points to weigh up. The stock last closed at US$96.82, with returns of 2.8% over the past week and 7.0% over the past month, while being down 4.0% year to date and 17.8% over the past year, as well as 30.9% and 33.6% over the past 3 and 5 years respectively. Recent news coverage has largely focused on Clorox's position in household...

Hexcel (NYSE:HXL) has entered a new long term industrial partnership with Deutsche Aircraft to supply composite solutions for the D328eco regional turboprop. The agreement covers advanced composite materials for primary and secondary structures on the D328eco, a next generation aircraft focused on environmental efficiency. The partnership was formalized at a major aerospace event and positions Hexcel within a key European program in regional aviation. For investors watching NYSE:HXL, this...

Why Tandem Diabetes Care Stock Is Back on Investor Radars Tandem Diabetes Care (TNDM) has drawn fresh attention after recent share price swings, with the stock up about 29% over the past month but down roughly 24% in the past 3 months. See our latest analysis for Tandem Diabetes Care. At a share price of $16.60, Tandem Diabetes Care has seen a 5.06% 1 day share price gain and a 29.49% 30 day share price return. This follows a 24.24% 90 day decline and a 22.97% year to date share price...

Conference spotlight and mixed analyst views put Madrigal Pharmaceuticals (MDGL) in focus Madrigal Pharmaceuticals (MDGL) is back on investors’ radar after recent analyst commentary on its MASH treatment Rezdiffra and plans to showcase fresh clinical and real world data at the upcoming EASL Congress 2026. The stock is also drawing attention ahead of Madrigal’s presentation at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, where management is expected to discuss...

UiPath (NYSE:PATH) reported that its Maestro platform has been used by One New Zealand Limited to revamp a complex telecom workflow. The deployment enabled near real-time mobile provisioning while keeping existing legacy systems in place. One New Zealand is now extending Maestro to additional mission critical processes after the initial rollout. For investors watching UiPath, this case highlights the company’s core pitch as an orchestration layer for automation and AI agents in large,...

Chinese regulators have reprimanded JD.com and other large e commerce platforms over misleading advertising and irregular discount practices during the 618 shopping festival. Authorities ordered immediate fixes to subsidy campaigns, price disclosures, and consumer protection measures tied to the event. The action signals closer scrutiny of how NasdaqGS:JD structures and markets its major sales promotions. For JD.com, trading at $28.56, the regulatory move comes after a period of weaker...

Wondering whether Globus Medical at around US$80.39 still offers value or if the easy money has already been made? This article breaks down what the current price might be implying about the stock. Globus Medical has returned 0.5% over the past week and 4.9% over the past month, while year to date the stock is down 7.9% and up 36.5% over the past year. Recent coverage has focused on how Globus Medical fits into broader interest in medical technology and healthcare equipment, as investors...